McArdle Laboratory for Cancer Research

McArdle Laboratory for Cancer Research is a biomedical research institute affiliated with the University of Wisconsin–Madison devoted to basic and translational studies in oncology. Founded with philanthropic support during the late 1930s and early 1940s, the laboratory has contributed to cell biology, molecular oncology, and clinical translation through interdisciplinary collaborations. Its work interfaces with academic centers, federal agencies, and private foundations to advance cancer prevention, diagnosis, and therapy.

History

The laboratory was established in 1940 following benefaction by John S. McArdle and guidance from leaders at the University of Wisconsin–Madison, emerging amid scientific advances promoted by institutions such as the Rockefeller Institute and the National Cancer Institute. Early decades saw studies influenced by discoveries from scientists associated with Oswald Avery, James Watson, Francis Crick, and contemporaneous work at Cold Spring Harbor Laboratory and Harvard University. Throughout the mid-20th century, investigators at the laboratory engaged with protocols refined at National Institutes of Health, participated in wartime research networks linked to Manhattan Project era science policy debates, and adopted technologies pioneered at Massachusetts Institute of Technology and Stanford University. The later 20th century brought molecular genetics techniques developed by groups at University of California, Berkeley, Johns Hopkins University, and University of Chicago, enabling advances in tumor virology and cell culture. In the 21st century the laboratory integrated genomic methods associated with consortia like The Cancer Genome Atlas and partnered with clinical centers including UW Health and cancer centers accredited by the American College of Surgeons.

Research Programs and Facilities

Research programs span experimental oncology influenced by paradigms from Peter Nowell and C. C. Little, molecular biology methods from Max Delbrück, and signaling pathways explored in labs of Tony Hunter and Lewis Cantley. Core facilities provide resources for genomics using platforms derived from technologies at Illumina and proteomics workflows similar to those at Broad Institute, as well as microscopy suites influenced by designs from Nikon Corporation and ZEISS. Programs include tumor immunology with conceptual ties to work by Jim Allison and Tasuku Honjo, cancer metabolism tracing approaches pioneered by Otto Warburg and extended by groups at University of California, San Diego, and cancer genetics building on findings from Bert Vogelstein and Michael Stratton. The laboratory houses vivarium facilities meeting standards promulgated by the Association for Assessment and Accreditation of Laboratory Animal Care International and clinical translational units coordinating with Food and Drug Administration frameworks and National Cancer Institute clinical trials infrastructure. Technology development collaborations have paralleled innovations at Thermo Fisher Scientific and computational partnerships referencing methods from Google DeepMind and Broad Institute bioinformatics teams.

Notable Scientists and Leadership

Leadership and investigators have included faculty with connections to Nobel-associated environments such as Francis Crick and mentoring lineages traceable to Joshua Lederberg and Salvador Luria. Alumni and visiting scientists have come from and gone on to positions at Harvard Medical School, Yale University, Columbia University, University of Pennsylvania, University of California, San Francisco, Memorial Sloan Kettering Cancer Center, Dana–Farber Cancer Institute, and Salk Institute. Distinguished researchers affiliated with the laboratory have had intellectual proximities to figures like Elizabeth Blackburn, Harold Varmus, Bert Vogelstein, and Robert Weinberg, and have collaborated with investigators from Fred Hutchinson Cancer Research Center and Scripps Research. Administrative leadership has navigated funding landscapes shaped by the National Institutes of Health, private benefactors such as the Gordon and Betty Moore Foundation, and philanthropic trusts resembling the Howard Hughes Medical Institute model.

Education, Training, and Outreach

The laboratory contributes to graduate and postdoctoral training programs within the University of Wisconsin–Madison Graduate School and professional education for trainees who pursue careers at institutions such as Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital. Trainees engage in curricula influenced by pedagogical models from Cold Spring Harbor Laboratory courses and attend symposia modeled after conferences like the American Association for Cancer Research annual meeting and the American Society of Clinical Oncology meetings. Community outreach includes public seminars with partners such as the Wisconsin Institute for Discovery, collaborative screening programs reminiscent of initiatives by Susan G. Komen affiliates, and policy engagement in forums involving representatives from the U.S. Congress and state health agencies.

Funding and Collaborations

Funding sources have included grants from the National Institutes of Health, program support from the National Cancer Institute, awards from foundations similar to the American Cancer Society, and philanthropic gifts in the tradition of major donors like Andrew Carnegie and Rockefeller Foundation patrons. The laboratory sustains collaborations with university departments at University of Wisconsin–Madison and external partnerships with entities such as Mayo Clinic, Cargill‑linked programs, biotechnology firms modeled on Genentech and Amgen, and consortiums resembling The Cancer Genome Atlas and the International Cancer Genome Consortium. Interinstitutional projects often align with regulatory and translational frameworks involving the Food and Drug Administration and cooperative agreements administered through the National Institutes of Health.

Category:University of Wisconsin–Madison research institutes